[저자] Kristian Reich, Kenji Kabashima, Ketty Peris, Jonathan I. Silverberg, Lawrence F. Eichenfield, Thomas Bieber, Aleksandra Kaszuba, Jill Kolodsick, Fan E. Yang, Margaret Gamalo, Dennis R. Brinker, Amy M. DeLozier, Jonathan M. Janes, Fabio P. Nunes, Jacob P. Thyssen, Eric L. Simpson
[Category] 대상포진,
[Article Type] Original Investigation
[Source] PMC
This randomized clinical trial assesses the efficacy and safety of 4 mg and 2 mg of baricitinib in combination with background topical corticosteroid therapy in adults with moderate to severe AD who previously had an inadequate response to topical corticosteroid therapy.
All Keywords